Request for Covid-19 Impact Assessment of this Report
The United States Human Growth Hormone Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Growth Hormone Drugs market, reaching US$ million by the year 2028. As for the Europe Human Growth Hormone Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Growth Hormone Drugs players cover Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), and GeneScience Pharmaceuticals Co., Ltd. (China), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Growth Hormone Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Growth Hormone Drugs by Country/Region, 2017, 2022 & 2028
2.2 Human Growth Hormone Drugs Segment by Type
2.2.1 Norditropin
2.2.2 Genotropin
2.2.3 Humatrope
2.2.4 Saizen
2.2.5 Omnitrope - the Somatropin Biosimilar
2.2.6 Somatropin Biopartners
2.3 Human Growth Hormone Drugs Sales by Type
2.3.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Growth Hormone Drugs Sale Price by Type (2017-2022)
2.4 Human Growth Hormone Drugs Segment by Application
2.4.1 Prader-Willi Syndrome
2.4.2 Turner Syndrome
2.4.3 Short Stature Homeobox Gene
2.4.4 Small for Gestational Age
2.4.5 Chronic Renal Insufficiency
2.4.6 Short Bowel Syndrome
2.5 Human Growth Hormone Drugs Sales by Application
2.5.1 Global Human Growth Hormone Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Human Growth Hormone Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Growth Hormone Drugs Sale Price by Application (2017-2022)
3 Global Human Growth Hormone Drugs by Company
3.1 Global Human Growth Hormone Drugs Breakdown Data by Company
3.1.1 Global Human Growth Hormone Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2022)
3.2 Global Human Growth Hormone Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Human Growth Hormone Drugs Revenue by Company (2020-2022)
3.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Human Growth Hormone Drugs Sale Price by Company
3.4 Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Growth Hormone Drugs Product Location Distribution
3.4.2 Players Human Growth Hormone Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Growth Hormone Drugs by Geographic Region
4.1 World Historic Human Growth Hormone Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Growth Hormone Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Growth Hormone Drugs Annual Revenue by Geographic Region
4.2 World Historic Human Growth Hormone Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Human Growth Hormone Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Growth Hormone Drugs Annual Revenue by Country/Region
4.3 Americas Human Growth Hormone Drugs Sales Growth
4.4 APAC Human Growth Hormone Drugs Sales Growth
4.5 Europe Human Growth Hormone Drugs Sales Growth
4.6 Middle East & Africa Human Growth Hormone Drugs Sales Growth
5 Americas
5.1 Americas Human Growth Hormone Drugs Sales by Country
5.1.1 Americas Human Growth Hormone Drugs Sales by Country (2017-2022)
5.1.2 Americas Human Growth Hormone Drugs Revenue by Country (2017-2022)
5.2 Americas Human Growth Hormone Drugs Sales by Type
5.3 Americas Human Growth Hormone Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Growth Hormone Drugs Sales by Region
6.1.1 APAC Human Growth Hormone Drugs Sales by Region (2017-2022)
6.1.2 APAC Human Growth Hormone Drugs Revenue by Region (2017-2022)
6.2 APAC Human Growth Hormone Drugs Sales by Type
6.3 APAC Human Growth Hormone Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Growth Hormone Drugs by Country
7.1.1 Europe Human Growth Hormone Drugs Sales by Country (2017-2022)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Country (2017-2022)
7.2 Europe Human Growth Hormone Drugs Sales by Type
7.3 Europe Human Growth Hormone Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Growth Hormone Drugs by Country
8.1.1 Middle East & Africa Human Growth Hormone Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Growth Hormone Drugs Sales by Type
8.3 Middle East & Africa Human Growth Hormone Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs
10.3 Manufacturing Process Analysis of Human Growth Hormone Drugs
10.4 Industry Chain Structure of Human Growth Hormone Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Growth Hormone Drugs Distributors
11.3 Human Growth Hormone Drugs Customer
12 World Forecast Review for Human Growth Hormone Drugs by Geographic Region
12.1 Global Human Growth Hormone Drugs Market Size Forecast by Region
12.1.1 Global Human Growth Hormone Drugs Forecast by Region (2023-2028)
12.1.2 Global Human Growth Hormone Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Growth Hormone Drugs Forecast by Type
12.7 Global Human Growth Hormone Drugs Forecast by Application
13 Key Players Analysis
13.1 Eli Lilly and Company (US)
13.1.1 Eli Lilly and Company (US) Company Information
13.1.2 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Offered
13.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly and Company (US) Main Business Overview
13.1.5 Eli Lilly and Company (US) Latest Developments
13.2 Ferring Holding SA (Switzerland)
13.2.1 Ferring Holding SA (Switzerland) Company Information
13.2.2 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Offered
13.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ferring Holding SA (Switzerland) Main Business Overview
13.2.5 Ferring Holding SA (Switzerland) Latest Developments
13.3 Genentech, Inc. (US)
13.3.1 Genentech, Inc. (US) Company Information
13.3.2 Genentech, Inc. (US) Human Growth Hormone Drugs Product Offered
13.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Genentech, Inc. (US) Main Business Overview
13.3.5 Genentech, Inc. (US) Latest Developments
13.4 GeneScience Pharmaceuticals Co., Ltd. (China)
13.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
13.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Offered
13.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Main Business Overview
13.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
13.5 Merck KgaA (Germany)
13.5.1 Merck KgaA (Germany) Company Information
13.5.2 Merck KgaA (Germany) Human Growth Hormone Drugs Product Offered
13.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck KgaA (Germany) Main Business Overview
13.5.5 Merck KgaA (Germany) Latest Developments
13.6 Novo Nordisk A/S (Denmark)
13.6.1 Novo Nordisk A/S (Denmark) Company Information
13.6.2 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Offered
13.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novo Nordisk A/S (Denmark) Main Business Overview
13.6.5 Novo Nordisk A/S (Denmark) Latest Developments
13.7 Pfizer, Inc. (US)
13.7.1 Pfizer, Inc. (US) Company Information
13.7.2 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Offered
13.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer, Inc. (US) Main Business Overview
13.7.5 Pfizer, Inc. (US) Latest Developments
13.8 Sandoz International GmbH (Germany)
13.8.1 Sandoz International GmbH (Germany) Company Information
13.8.2 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Offered
13.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sandoz International GmbH (Germany) Main Business Overview
13.8.5 Sandoz International GmbH (Germany) Latest Developments
14 Research Findings and Conclusion
Table 1. Human Growth Hormone Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Growth Hormone Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Norditropin
Table 4. Major Players of Genotropin
Table 5. Major Players of Humatrope
Table 6. Major Players of Saizen
Table 7. Major Players of Omnitrope - the Somatropin Biosimilar
Table 8. Major Players of Somatropin Biopartners
Table 9. Global Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
Table 11. Global Human Growth Hormone Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global Human Growth Hormone Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Table 16. Global Human Growth Hormone Drugs Revenue by Application (2017-2022)
Table 17. Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global Human Growth Hormone Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Human Growth Hormone Drugs Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2022)
Table 21. Global Human Growth Hormone Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global Human Growth Hormone Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution and Sales Area
Table 25. Players Human Growth Hormone Drugs Products Offered
Table 26. Human Growth Hormone Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Human Growth Hormone Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Human Growth Hormone Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global Human Growth Hormone Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Human Growth Hormone Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Human Growth Hormone Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global Human Growth Hormone Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Human Growth Hormone Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC Human Growth Hormone Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Human Growth Hormone Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Human Growth Hormone Drugs
Table 70. Key Market Challenges & Risks of Human Growth Hormone Drugs
Table 71. Key Industry Trends of Human Growth Hormone Drugs
Table 72. Human Growth Hormone Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Human Growth Hormone Drugs Distributors List
Table 75. Human Growth Hormone Drugs Customer List
Table 76. Global Human Growth Hormone Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Human Growth Hormone Drugs Sales Market Forecast by Region
Table 78. Global Human Growth Hormone Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Human Growth Hormone Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Human Growth Hormone Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Human Growth Hormone Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Human Growth Hormone Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Human Growth Hormone Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Human Growth Hormone Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Human Growth Hormone Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Human Growth Hormone Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Eli Lilly and Company (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Offered
Table 98. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. Eli Lilly and Company (US) Main Business
Table 100. Eli Lilly and Company (US) Latest Developments
Table 101. Ferring Holding SA (Switzerland) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Offered
Table 103. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. Ferring Holding SA (Switzerland) Main Business
Table 105. Ferring Holding SA (Switzerland) Latest Developments
Table 106. Genentech, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Genentech, Inc. (US) Human Growth Hormone Drugs Product Offered
Table 108. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Genentech, Inc. (US) Main Business
Table 110. Genentech, Inc. (US) Latest Developments
Table 111. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Offered
Table 113. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. GeneScience Pharmaceuticals Co., Ltd. (China) Main Business
Table 115. GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments
Table 116. Merck KgaA (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Merck KgaA (Germany) Human Growth Hormone Drugs Product Offered
Table 118. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Merck KgaA (Germany) Main Business
Table 120. Merck KgaA (Germany) Latest Developments
Table 121. Novo Nordisk A/S (Denmark) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Offered
Table 123. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Novo Nordisk A/S (Denmark) Main Business
Table 125. Novo Nordisk A/S (Denmark) Latest Developments
Table 126. Pfizer, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Offered
Table 128. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Pfizer, Inc. (US) Main Business
Table 130. Pfizer, Inc. (US) Latest Developments
Table 131. Sandoz International GmbH (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Offered
Table 133. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. Sandoz International GmbH (Germany) Main Business
Table 135. Sandoz International GmbH (Germany) Latest Developments
List of Figures
Figure 1. Picture of Human Growth Hormone Drugs
Figure 2. Human Growth Hormone Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Growth Hormone Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Human Growth Hormone Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Growth Hormone Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Norditropin
Figure 10. Product Picture of Genotropin
Figure 11. Product Picture of Humatrope
Figure 12. Product Picture of Saizen
Figure 13. Product Picture of Omnitrope - the Somatropin Biosimilar
Figure 14. Product Picture of Somatropin Biopartners
Figure 15. Global Human Growth Hormone Drugs Sales Market Share by Type in 2021
Figure 16. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2022)
Figure 17. Human Growth Hormone Drugs Consumed in Prader-Willi Syndrome
Figure 18. Global Human Growth Hormone Drugs Market: Prader-Willi Syndrome (2017-2022) & (K Pcs)
Figure 19. Human Growth Hormone Drugs Consumed in Turner Syndrome
Figure 20. Global Human Growth Hormone Drugs Market: Turner Syndrome (2017-2022) & (K Pcs)
Figure 21. Human Growth Hormone Drugs Consumed in Short Stature Homeobox Gene
Figure 22. Global Human Growth Hormone Drugs Market: Short Stature Homeobox Gene (2017-2022) & (K Pcs)
Figure 23. Human Growth Hormone Drugs Consumed in Small for Gestational Age
Figure 24. Global Human Growth Hormone Drugs Market: Small for Gestational Age (2017-2022) & (K Pcs)
Figure 25. Human Growth Hormone Drugs Consumed in Chronic Renal Insufficiency
Figure 26. Global Human Growth Hormone Drugs Market: Chronic Renal Insufficiency (2017-2022) & (K Pcs)
Figure 27. Human Growth Hormone Drugs Consumed in Short Bowel Syndrome
Figure 28. Global Human Growth Hormone Drugs Market: Short Bowel Syndrome (2017-2022) & (K Pcs)
Figure 29. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)
Figure 30. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2021
Figure 31. Human Growth Hormone Drugs Revenue Market by Company in 2021 ($ Million)
Figure 32. Global Human Growth Hormone Drugs Revenue Market Share by Company in 2021
Figure 33. Global Human Growth Hormone Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region in 2021
Figure 35. Global Human Growth Hormone Drugs Sales Market Share by Region (2017-2022)
Figure 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region in 2021
Figure 37. Americas Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)
Figure 38. Americas Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)
Figure 39. APAC Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)
Figure 40. APAC Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Europe Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)
Figure 42. Europe Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)
Figure 44. Middle East & Africa Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)
Figure 45. Americas Human Growth Hormone Drugs Sales Market Share by Country in 2021
Figure 46. Americas Human Growth Hormone Drugs Revenue Market Share by Country in 2021
Figure 47. United States Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC Human Growth Hormone Drugs Sales Market Share by Region in 2021
Figure 52. APAC Human Growth Hormone Drugs Revenue Market Share by Regions in 2021
Figure 53. China Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. India Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe Human Growth Hormone Drugs Sales Market Share by Country in 2021
Figure 60. Europe Human Growth Hormone Drugs Revenue Market Share by Country in 2021
Figure 61. Germany Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. France Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country in 2021
Figure 67. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country in 2021
Figure 68. Egypt Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2021
Figure 74. Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure 75. Industry Chain Structure of Human Growth Hormone Drugs
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...